129 related articles for article (PubMed ID: 37706238)
21. MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Laé M; Gardrat S; Rondeau S; Richardot C; Caly M; Chemlali W; Vacher S; Couturier J; Mariani O; Terrier P; Bièche I
Oncotarget; 2016 Dec; 7(51):84428-84438. PubMed ID: 27806318
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing.
Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2015 Jul; 152(2):305-12. PubMed ID: 26093648
[TBL] [Abstract][Full Text] [Related]
23. Frequent MED12 mutations in phyllodes tumours of the breast.
Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A
Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987
[TBL] [Abstract][Full Text] [Related]
24. Invasive and Non-invasive Ductal Carcinoma within Malignant Phyllodes Tumour with Axillary Lymph Node Metastases.
Erdogan O; Parlakgumus A; Tas ZA; Yener K; Turan U
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S92-S94. PubMed ID: 36210658
[TBL] [Abstract][Full Text] [Related]
25. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.
Lim SZ; Ng CCY; Rajasegaran V; Guan P; Selvarajan S; Thike AA; Nasir NDBM; Koh VCY; Tan BKT; Ong KW; Teh BT; Tan PH
Breast Cancer Res Treat; 2019 Apr; 174(2):365-373. PubMed ID: 30511242
[TBL] [Abstract][Full Text] [Related]
26. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
[TBL] [Abstract][Full Text] [Related]
27. Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.
Otsuji K; Sasaki T; Tanabe M; Seto Y
Br J Cancer; 2021 Jan; 124(2):466-473. PubMed ID: 33046803
[TBL] [Abstract][Full Text] [Related]
28. Identification of clinically relevant alterations in phyllodes tumor of the breast by amplicon-based next-generation sequencing.
Tsang JY; Go EM; Tse GM
Breast Cancer Res Treat; 2015 Jun; 151(3):717-9. PubMed ID: 25900796
[No Abstract] [Full Text] [Related]
29. Lymph Node and Distant Metastases in Phyllodes Tumor of the Breast.
Naal T; Saker S; Coldren D
Int J Surg Pathol; 2023 Aug; 31(5):761-764. PubMed ID: 36285397
[TBL] [Abstract][Full Text] [Related]
30. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
31. Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade.
Yoon N; Bae GE; Kang SY; Choi MS; Hwang HW; Kim SW; Lee JE; Nam SJ; Gong G; Lee HJ; Bae YK; Lee A; Cho EY
Genes Chromosomes Cancer; 2016 Jun; 55(6):495-504. PubMed ID: 26856273
[TBL] [Abstract][Full Text] [Related]
32. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression.
Tan WJ; Chan JY; Thike AA; Lim JC; Md Nasir ND; Tan JS; Koh VC; Lim WK; Tan J; Ng CC; Rajasegaran V; Nagarajan S; Bay BH; Teh BT; Tan PH
J Clin Pathol; 2016 Oct; 69(10):858-65. PubMed ID: 27056456
[TBL] [Abstract][Full Text] [Related]
33. Jejunal intussusception due to malignant phyllodes tumor of the breast.
Bilen MA; Laucirica R; Rimawi MF; Nangia JR; Cyprus GS
Clin Breast Cancer; 2012 Jun; 12(3):219-21. PubMed ID: 22381472
[TBL] [Abstract][Full Text] [Related]
34. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
[TBL] [Abstract][Full Text] [Related]
35. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.
Fajdić J; Gotovac N; Hrgović Z; Kristek J; Horvat V; Kaufmann M
Onkologie; 2007 Mar; 30(3):113-8. PubMed ID: 17341897
[TBL] [Abstract][Full Text] [Related]
36. Cystosarcoma phyllodes: report of two cases.
Dahniya MH; Hanna RM; Ashebu SD
East Afr Med J; 2004 Oct; 81(10):546-8. PubMed ID: 15715136
[TBL] [Abstract][Full Text] [Related]
37. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract][Full Text] [Related]
38. A Case of Malignant Phyllodes Tumor of the Breast Metastasizing to the Ovary.
Tada Y; Yasunaga M; Tomonobe H; Yamada Y; Hori E; Okugawa K; Yahata H; Oda Y; Kato K
Int J Surg Pathol; 2022 Jun; 30(4):427-431. PubMed ID: 34761702
[TBL] [Abstract][Full Text] [Related]
39. Osteosarcoma mimic in the breast: A recurrent malignant phyllodes tumour harbouring MED12 and hTERT mutations.
Tokoyoda M; Adachi S; Ishida Y; Yamazaki K
Cytopathology; 2018 Aug; 29(4):383-385. PubMed ID: 29633481
[No Abstract] [Full Text] [Related]
40. Genomic landscapes of breast fibroepithelial tumors.
Tan J; Ong CK; Lim WK; Ng CC; Thike AA; Ng LM; Rajasegaran V; Myint SS; Nagarajan S; Thangaraju S; Dey S; Nasir ND; Wijaya GC; Lim JQ; Huang D; Li Z; Wong BH; Chan JY; McPherson JR; Cutcutache I; Poore G; Tay ST; Tan WJ; Putti TC; Ahmad BS; Iau P; Chan CW; Tang AP; Yong WS; Madhukumar P; Ho GH; Tan VK; Wong CY; Hartman M; Ong KW; Tan BK; Rozen SG; Tan P; Tan PH; Teh BT
Nat Genet; 2015 Nov; 47(11):1341-5. PubMed ID: 26437033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
